<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 7-year-old girl with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> and moderately severe <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> experienced a <z:hpo ids='HP_0001297'>stroke</z:hpo> while being treated with a <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Angiography identified bilateral stenosis of the supraclinoid internal carotid arteries, stenosis or occlusion of the proximal anterior and middle cerebral arteries, and occlusion of the left posterior cerebral artery </plain></SENT>
<SENT sid="2" pm="."><plain>She underwent surgery to enhance collateral blood flow to vulnerable areas of the brain </plain></SENT>
<SENT sid="3" pm="."><plain>Her <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> therapy was changed to an oral <z:chebi fb="0" ids="51451">endothelin receptor antagonist</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>She developed excellent collateral blood flow through external carotid arteries to each cerebral hemisphere and an improvement in blood flow through the right internal carotid artery </plain></SENT>
<SENT sid="5" pm="."><plain>This case suggests that <z:chebi fb="0" ids="51450">bosentan</z:chebi> can be used safely in children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Additional studies are needed to determine whether <z:chebi fb="0" ids="51451">endothelin receptor antagonists</z:chebi> may influence the progression of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> or the development of collateral cerebral blood flow following surgery </plain></SENT>
</text></document>